Article Text

Download PDFPDF
Combination treatment strategies in early rheumatoid arthritis


Combinations of disease modifying antirheumatic drugs (DMARDs) are increasingly being used in patients with early rheumatoid arthritis (RA) when long term results with sequential DMARD monotherapy are disappointing. Combination DMARD therapy may be more effective than monotherapy, and has no additional short term adverse events. The evidence for using combination DMARD therapy is still weak, however, and further trials are needed.

  • ACR, American College of Rheumatology
  • DMARD, disease modifying antirheumatic drug
  • RA, rheumatoid arthritis
  • TNF, tumour necrosis factor
  • combination therapy
  • early rheumatoid arthritis

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.